Publications by authors named "Ivan de Dios"

Claim this Profile
G
Genome sequencing reveals the impact of pseudoexons in rare genetic disease.
Georgia Pitsava, Megan Hawley, Light Auriga, Ivan de Dios, Arthur Ko

Genet Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome sequencing reveals the impact of pseudoexons in rare genetic disease.
Georgia Pitsava, Megan Hawley, Light Auriga, Ivan de Dios, Arthur Ko

medRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-read sequencing resolves the clinically relevant locus, supporting a new clinical test for Congenital Adrenal Hyperplasia.
Jean Monlong, Xiao Chen, Hayk Barseghyan, William J Rowell, Shloka Negi, Ivan de Dios

medRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous Recombination Abnormalities Associated With Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data.
Maher Albitar, Hong Zhang, Andrew Pecora, Stanley Waintraub, Deena Graham, Ivan De Dios

Breast Cancer (Auckl)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial Intelligence.
Hong Zhang, Muhammad A Qureshi, Mohsin Wahid, Ahmad Charifa, Aamir Ehsan, Ivan De Dios

Am J Pathol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms.
Andrew Ip, Alexandra Della Pia, Gee Youn Geeny Kim, Jason Lofters, James Behrmann, Ivan De Dios

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL.
Zijun Y Xu-Monette, Hongwei Zhang, Feng Zhu, Alexandar Tzankov, Govind Bhagat, Ivan De Dios

Blood Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors.
Adam Albitar, Wanlong Ma, Ivan DeDios, Jeffrey Estella, Inhye Ahn

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Sequencing of Cell-Free Peripheral Blood DNA as a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome.
Ferras Albitar, Wanlong Ma, Kevin Diep, Ivan De Dios, Sally Agersborg

Genet Test Mol Biomarkers· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis